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Abstract
Recent, media-hyped controversy has centred on whether
there is any link between the combined measles-mumps-rubella
(MMR) vaccine and autism or inflammatory bowel disease. The
exhaustive available evidence fails to support any such
association, yet the known high morbidity and mortality from
these conditions has not prevented a small group of concerned
parents from failing to vaccinate their children. This paper will
outline the reasons and misconceptions behind the current
MMR scare. Further efforts are necessary to completely allay
the public’s unfounded fears.
Introduction
Measles, mumps and rubella are contagious viral illness is
that are usually contracted in childhood in non-immunised
individuals. The MMR (measles, mumps and rubella) vaccine
is a live vaccine designed to protect against measles, mumps
and rubella, and was well tolerated and well received by children,
parents and doctors alike. 5-10% of children do not develop
antibodies to one dose of vaccine, so a pre-school booster is
given at 3-5 years, and this two-dose schedule leads to an efficacy
of 99%.1 The measles vaccine was first made available in Malta
in 1982 as part of the National Childhood Immunization
Schedule, and as the MMR vaccine in 1987, and was introduced
into the National Childhood Immunization Schedule in 1990.2
MMR vaccination was introduced in the UK in 1988, with the
first dose aimed at children aged 12-15 months.
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The MMR Controversy
On February 28, 1998, Dr. Andrew Wakefield reported in
The Lancet a possible association between inflammatory bowel
disease, autism, and viral infection associated with MMR
vaccination.3 This was a descriptive report on twelve children
who had been referred to a paediatric gastroenterology clinic
with both bowel symptoms and pervasive developmental
disorder characterised by loss of skills that had been previously
acquired – a form of autism. Testing of these children included
blood tests, cerebrospinal fluid tapping and gastrointestinal
biopsies obtained endoscopically and the investigators
attempted to explore the extent of bowel inflammation and to
exclude other diseases. The paper has several flaws which have
been criticised objectively by many independent scientists:
• There was no clear stated research hypothesis.
• The study group was highly selected, extremely small, had
no blinded investigators, included no controls, had a very
short follow-up period and was therefore inherently
incapable of proving or excluding a causal link between
MMR and autism and/or inflammatory bowel disease.
• The alleged link with MMR vaccination was made solely on
the basis of retrospective parental recall, that is, parents who
had signed a consent form to take part in a study to
determine a causal link between MMR and autism were
asked to remember how closely in time the vaccine was with
the onset of autism-like behaviour pattern in their child,
instantly invoking the spectre of recall bias. This modus
operandi is unreasonable because autism is known to
develop over a period of weeks or months, hence the
questionnaire asking for a link of forty-eight hours to two
weeks between vaccination and onset of abnormal behaviour
is scientifically implausible.
• No test was consistently abnormal in all of the children.
• Eleven had microscopic evidence only of inflammatory
reaction in their bowel.
• The study was not approved by any ethics committee despite
a battery of invasive tests including endoscopies, and the
study contravenes several sections of the Helsinki
Declaration,8 particularly: ‘The design and performance of
each experimental procedure involving human subjects
should be clearly formulated in an experimental protocol
which should be transmitted for consideration, comment
and guidance to a specially appointed committee
independent of the investigator’.
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Table 1: Diseases and Complications
Measles - 30% have at least one complication including:
• Diarrhoea (commonest cause of death in developing
countries).
• Otitis media with significant risk of deafness.
• 1ry viral/2ry bacterial pneumonia in 1:20 cases
(commonest cause of death in developed countries).
• Bronchitis, croup, sinusitis.
• Conjunctivitis/corneal ulceration may cause blindness
especially in Vit. A deficiency.
• Gangrenous stomatitis.
• Acute glomerulonephritis that may cause acute renal
failure.
• Malnutrition, hepatitis. mesenteric adenitis.
• Increased risk of premature labour and fetal loss.
• Myocarditis.
• Thrombocytopaenic purpura.
• Acute encephalitis in 1:1000 cases: 15% mortality &
30% permanent disability.17
• Subacute sclerosing panencephalitis (SSPE) in
1-4: 100,000 individuals: 100% fatal.18,19
• Mortality rates: 1 in 3,000 in developed countries, up
to 1 in 5 in developing countries.
Mumps
• Meningoencephalitis in 1:300 cases: high fatality rate
• Nephritis and myocarditis may also be fatal.
• 1st trimester disease: 25% fetal loss.
• Mumps orchitis in postpubertal males only causes
sterility if bilateral.
• Otitis: one of the most frequent causes of unilateral
hearing loss.20
Rubella
• Arthropathies of the fingers, wrists, and knees may
persist for over a year.
• Thrombocytopenia with purpura and hemorrhage is
extremely rare.
• Congenital rubella syndrome: multi-organ system
malformations including cardiac, ocular, CNS, and
skeletal systems especially in the first trimester.21
Wakefield called a press conference to launch the paper, an
unusual step for a medical researcher to call a national press
conference in order to announce the results of a scientific trial.
For a prestigious teaching hospital to do so for a study
concerning just twelve children was rather extraordinary. At
the briefing, Wakefield discredited the vaccine as posing risks
of causing autism and inflammatory bowel disease. He is also
on record as saying that he had a ‘feeling’ that the risk of autism
was related to the combined MMR vaccine, rather than the single
vaccines. A storm of controversy erupted, fomented by a media
frenzy, and the resulting global scare was immediate. MMR
vaccination rates in England fell from 92% of children reaching
the age of two in 1996-97 to 82% in 2002-034 and confirmed
cases of measles rose from 112 in 1996 to 442 in 2003.
In the interim, it has been alleged that Dr. Wakefield – the
paper’s lead author and senior investigator – may also have been
guilty of professional misconduct for several reasons. Wakefield
had not disclosed that he had been commissioned by the Legal
Aid Board (for the sum of £55,000) to determine whether there
was any evidence to support legal action by parents of children
allegedly harmed by the vaccine. Legal Aid is available in the
UK to fund eligible individuals in their quest to protect their
rights. Legal Aid also funds a network of solicitors, Citizens
Advice Bureaux and other advice providers. Help varies from
information leaflets and directing people to other services, to
specialist advice and taking cases to court where necessary. In
effect, Wakefield had been funded through solicitors seeking
evidence to use against vaccine manufacturers, and some of
these children had been included as subjects in Wakefield’s
paper. Wakefield did not disclose this conflict of interest either
during or after the research to his colleagues, medical authorities
or journal editorial board and the facts only came to light during
an investigation led by a Sunday Times of London Journalist,
Brian Deer.5 This led to the partial retraction of the article by
eleven of its thirteen authors (not including Wakefield), 6 and
the Lancet’s Editor, Richard Horton, partially retracted the
article, calling it ‘fatally flawed’.7
It has also been alleged that Dr. Wakefield failed to reveal
that he was developing his own commercial rival product to the
conventional accepted vaccine and that he had made a series of
applications to patent measles-related products. The first was
filed at the Patent Office just nine months before Wakefield’s
press conference in February 1998, and two more were filed on
June 4, 1998. The patent application papers detail products
aimed at preventing and even curing diseases allegedly caused
by MMR, and included transfer factors, a now largely abandoned
fringe conjecture based on a theory that desirable chemicals can
be harvested from white blood cells. The proposal included
injecting mice with measles, extracting and processing white
cells, injecting the result into pregnant goats, milking them after
kid-birth and turning the product into capsules for children,9
and was to be done with the help of a neurolgist.10
Further doubts have been cast on the original paper as the
High Court in London has requested that the Irish courts order
Professor John O’Leary, the Dublin pathologist who carried out
the study, to hand over all the raw data so that it can be re-
examined by independent experts following claims of anomalies
in O’Leary’s laboratory reports on samples from hundreds of
autistic children who are allegedly victims of the MMR vaccine.
Unigenetics, O’Leary’s private company, found that 80% of the
91 autistic children it had tested had traces of measles in their
bodies, presumably as a result of MMR vaccination.11 Two other
laboratories, testing samples from the same children, failed to
confirm O’Leary’s findings. One, at Edinburgh University, had
been commissioned by the drug companies, and the other, at
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Table 2: Common parent MMR misgivings and misconceptions
• Diseases had already begun to disappear before vaccines were introduced
(because of better hygiene and sanitation)
True but regular peaks due to outbreaks still appeared, and were potentially equally devastating to those affected.
• The majority of people who still get disease have been vaccinated
True because of statistics. Since the majority are vaccinated, and vaccines have a know (albeit small) failure rate, then this
sort of statistic is inevitable.
• Thiomersal (a mercury containing compound) is present in MMR
False, ethylmercury (thiomersal) is not present in MMR and never has been, and anyway, the presence of this compound
in other vaccines has not been linked to any adverse effects.
• There are ‘hot lots’  of vaccine that have been associated with more adverse events and deaths than others
Simply untrue.
• Giving a child multiple vaccinations for different diseases at the same time increases the risk of harmful
side effects and can overload the immune system
Children are exposed to a multitude of foreign antigens on a daily basis, including simply by eating through the introduction
of food antigens and bacteria. It is estimated that an upper respiratory viral infection exposes a child to 4-10 antigens, and
a case of streptococcal throat infection to 25-50 antigens. There is no proof whatsoever that giving vaccines separately
makes any sort of difference whatsoever apart from necessitating multiple doctor visits, increasing the number of jabs
exponentially, increasing costs, delaying the vaccination process with risk of disease acquisition and reducing compliance.
• Vaccines cause many harmful side effects, illnesses, and even death - not to mention possible long-term
effects we don’t even know about
Vaccine development typically takes 10 years, post-marketing surveillance by pharmaceutical companies is intensive and
taken very seriously. For example, a potential rotavirus vaccine was recently released and rapidly withdrawn after an
association was noted with intussusception. With regard to risks of vaccine versus disease, see paper itself!
• Vaccine-preventable diseases have been virtually eliminated, so there is no need for my child
to be vaccinated
False, uptake rates are not sufficiently high for herd immunity to be sufficient for this statement to be true. Conversely, if
uptake rates were to be high enough for this statement to be correct, a very small decline in vaccine uptake would return
us to an outbreak potential state.
Queen Mary Medical School, London, by the children’s lawyers.12
The entire issue is currently the subject of a General Medical
Council inquiry.
More importantly, studies since have failed to show any links
between autism, inflammatory bowel disease and MMR
vaccination. For example, a Finnish study prospectively followed
1.8 million children after MMR vaccination for fourteen years
and reported a total of 437 vaccine-associated events including
allergic reactions and convulsions, but autism could not be
linked to the vaccine.13 Furthermore, an analysis of 500 cases
of autism found no excess in MMR-immunised children.14
Another large study analysed the incidence of inflammatory
bowel disease in individuals who had received the MMR vaccine,
other measles-containing vaccines, and no vaccine at all, and
showed that the risk of inflammatory bowel disease was the
same for vaccinated or unvaccinated individuals, and not related
to early age at vaccination.15 Moreover, the National Autism
Society has stated that regressive autism – the type identified
by Wakefield – has remained constant since the introduction
of the MMR vaccine.16  The overall conclusions were that
reported adverse reactions established that serious events
causally related to MMR vaccine are rare and are greatly
outweighed by the risks of wild measles, mumps and rubella.
Known complications of wild viral infection
Measles has been called the greatest killer of children in
history and remains the leading cause of vaccine preventable
deaths in children worldwide. Because of poverty, with low
worldwide availability of vaccine, some 50 million individuals
contract the disease annually with over one million deaths per
annum. The highest incidence of measles and its associated
morbidity and mortality is witnessed in developing countries.
Complications of measles, mumps and rubella are briefly listed
in Table 1. All of these complications are vaccine preventable
and at this time, it is hoped that the MMR scare will fade away
like the similar pertussis vaccine scare of the 1970s.22  Table 2
lists some common misconceptions and questions that parents
come forward with, and possible replies based on science.
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It is likely that had Dr. Wakefield declared his conflicts of
interest, the paper would not have been accepted for publication.
Conflict of interest is a crucial principle that has long been
enshrined in the organisation of scientific research,23 and this
is especially important when one reviews the growing body of
evidence that demonstrates how conflict of interest biases
research outcomes. Systematic reviews have unequivocally
shown that results of sponsored studies are more likely to favour
the sponsor when it is a pharmaceutical company.24 Moreover,
industry-sponsored studies are not only associated with pro-
industry conclusions, but also lead to restrictions on publication
and data sharing.25
Conclusions
It is important to emphasise that the morbidity and
mortality related to wild virus infection are not theoretical issues
and are eminently vaccine-preventable, and this should be
highlighted to misinformed and concerned parents who may
be reluctant to vaccinate their children because of conjectural
and unproven vaccine side-effects.
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